phenformin has been researched along with Ataxia Telangiectasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; Hu, X; Huang, L; Huang, M; Li, G; Qin, M; Tang, J; Wu, J; Wu, T; Xiao, D; Yan, X; Yang, X; Zhou, S | 1 |
1 other study(ies) available for phenformin and Ataxia Telangiectasia
Article | Year |
---|---|
Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Topics: AMP-Activated Protein Kinases; Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; China; Drug Synergism; Drug Therapy, Combination; Humans; Liver Neoplasms; Mitochondria; Morpholines; Phenformin; Phosphorylation; Pyrones; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2021 |